Plugin

Advertisement

BioMarin Pharma Biotech stock gains favor among mutual fund managers The Investor Business Daily | Jobs Vox

[ad_1] BioMarin Pharmaceuticals (BMRN) executed a high bullish gap in late November when it broke out of a double-bottom base with a 92.86 buy point. Volume was strong and supported the jump. The biotech stock is currently grinding in an extended range and is waiting to find a new base pattern. X Biotech stock’s strong … Read moreBioMarin Pharma Biotech stock gains favor among mutual fund managers The Investor Business Daily

| Jobs Vox

Implement tags. Simulate a mobile device using Chrome Dev Tools Device Mode. Scroll page to activate.

x